Bright Green enters into restructuring security agreement with Lynn Stockwell

Restructuring Agreement: Lynn Stockwell has reached a restructuring security agreement with Bright Green Corporation, aiming to realign the company towards on-shoring active pharmaceutical ingredient manufacturing in the U.S., which includes canceling existing contracts and leadership changes.

Future Plans: The company plans to establish production contracts for plant-based controlled substances, explore franchise opportunities for agricultural facilities across several states, and maintain partnerships with Health and Human Services for research support.